The earnings call highlighted strong revenue growth and gross margin improvements, as well as strategic steps towards achieving profitability and regulatory progress in the U.S. However, challenges persist with declining sales in Germany and an increased net loss. The overall sentiment is cautiously optimistic as the company addresses these issues.

Company Guidance

In the third quarter of 2025, CytoSorbents Corp. reported a revenue of $9.5 million, marking a 10% increase from $8.6 million in the previous year, or 4% on a constant currency basis. The company's trailing 12-month core product sales reached a record $37 million as of September 30, 2025. Gross margin rose to approximately 70%, compared to 61% in the third quarter of 2024. Distributor and partner sales grew by 14% to $15.6 million, while direct sales outside of Germany increased by 24% to $8.8 million. However, sales in Germany declined by 3% to $12.6 million. Overall sales growth was 9%, or 17% when excluding Germany. The company has implemented a strategic workforce and cost reduction program, including a 10% workforce reduction, to achieve cash flow breakeven by Q1 2026. Operating expenses decreased by 6% to $9.5 million, with a net loss of $3.2 million for the quarter. CytoSorbents has also amended its loan agreement with Avenue Partners, securing $2.5 million in new capital and extending the interest-only period.

Record Core Product Sales

Trailing 12-month core product sales reached a record $37 million as of September 30, 2025, supported by strong execution across the global network.

Gross Margin Improvement

Gross margin remained strong at approximately 70%, an improvement from 61% in the third quarter of 2024.

Revenue Growth

Third quarter revenue was $9.5 million, up 10% from $8.6 million a year ago, or 4% on a constant currency basis.

Regulatory Progress for DrugSorb-ATR

Filed a formal pre-submission meeting request with the FDA on November 7, 2025, and anticipates a pre-submission meeting in late 2025 or early Q1 of '26.

Cost Reduction and Strategic Workforce Program

Implemented a strategic workforce and cost reduction program, including a 10% workforce reduction, to achieve cash flow breakeven by Q1 2026.

Cytosorbents (CTSO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CTSO Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Mar 05, 2026	2025 (Q4)	-0.04 / -	-0.14	―	―	―
Nov 13, 2025	2025 (Q3)	-0.04 / -0.04	-0.04	0.00% (0.00)
Aug 07, 2025	2025 (Q2)	-0.05 / 0.03	-0.08	137.50% (+0.11)	―
May 14, 2025	2025 (Q1)	- / -0.02	-0.12	83.33% (+0.10)
Mar 31, 2025	2024 (Q4)	-0.07 / -0.02	-0.12	83.33% (+0.10)
Nov 07, 2024	2024 (Q3)	-0.06 / -0.04	-0.21	80.95% (+0.17)
Aug 13, 2024	2024 (Q2)	-0.10 / -0.08	-0.14	42.86% (+0.06)
May 09, 2024	2024 (Q1)	-0.12 / -0.12	-0.17	29.41% (+0.05)	―
Mar 14, 2024	2023 (Q4)	-0.14 / -0.12	-0.01	-1100.00% (-0.11)	―
Nov 09, 2023	2023 (Q3)	-0.12 / -0.21	-0.28	25.00% (+0.07)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CTSO Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 13, 2025	$0.66	$0.66	0.00%
Aug 07, 2025	$0.89	$1.00	+12.36%
May 14, 2025	$0.81	$0.83	+2.47%
Mar 31, 2025	$1.00	$1.00	0.00%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Cytosorbents Corp (CTSO) report earnings?

Cytosorbents Corp (CTSO) is schdueled to report earning on Mar 05, 2026, After Close (Confirmed).

What is Cytosorbents Corp (CTSO) earnings time?

Cytosorbents Corp (CTSO) earnings time is at Mar 05, 2026, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is CTSO EPS forecast?

CTSO EPS forecast for the fiscal quarter 2025 (Q4) is -0.04.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing